Auxly Cannabis Group Stock Price To Earnings To Growth
XLY Stock | CAD 0.04 0.01 16.67% |
Auxly Cannabis Group fundamentals help investors to digest information that contributes to Auxly Cannabis' financial success or failures. It also enables traders to predict the movement of Auxly Stock. The fundamental analysis module provides a way to measure Auxly Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auxly Cannabis stock.
Auxly | Price To Earnings To Growth |
Auxly Cannabis Group Company Price To Earnings To Growth Analysis
Auxly Cannabis' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Auxly Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Auxly Cannabis is extremely important. It helps to project a fair market value of Auxly Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Auxly Cannabis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Auxly Cannabis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Auxly Cannabis' interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Auxly Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Auxly Cannabis Group has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The price to earnings to growth for all Canada stocks is 100.0% higher than that of the company.
Auxly Cannabis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Auxly Cannabis from analyzing Auxly Cannabis' financial statements. These drivers represent accounts that assess Auxly Cannabis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Auxly Cannabis' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 322.1M | 161.0M | 144.9M | 17.8M | 9.9M | 9.4M | |
Enterprise Value | 377.7M | 264.5M | 320.3M | 196.8M | 153.3M | 80.5M |
Auxly Fundamentals
Return On Equity | -0.52 | ||||
Return On Asset | -0.0309 | ||||
Profit Margin | (0.41) % | ||||
Operating Margin | 0.17 % | ||||
Current Valuation | 96.4 M | ||||
Shares Outstanding | 1.25 B | ||||
Shares Owned By Insiders | 21.73 % | ||||
Shares Owned By Institutions | 0.24 % | ||||
Number Of Shares Shorted | 348.01 K | ||||
Price To Book | 0.39 X | ||||
Price To Sales | 0.41 X | ||||
Revenue | 101.08 M | ||||
Gross Profit | 19.29 M | ||||
EBITDA | (30.95 M) | ||||
Net Income | (44.51 M) | ||||
Cash And Equivalents | 14.64 M | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 159.04 M | ||||
Debt To Equity | 1.20 % | ||||
Current Ratio | 2.58 X | ||||
Book Value Per Share | 0.05 X | ||||
Cash Flow From Operations | 8.21 M | ||||
Short Ratio | 0.88 X | ||||
Earnings Per Share | (0.07) X | ||||
Target Price | 0.02 | ||||
Number Of Employees | 369 | ||||
Beta | 1.22 | ||||
Market Capitalization | 44.93 M | ||||
Total Asset | 261.9 M | ||||
Retained Earnings | (483.27 M) | ||||
Working Capital | (38.98 M) | ||||
Net Asset | 261.9 M |
About Auxly Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Auxly Cannabis Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Auxly Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Auxly Cannabis Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Auxly Stock
Auxly Cannabis financial ratios help investors to determine whether Auxly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Auxly with respect to the benefits of owning Auxly Cannabis security.